Navigation Links
Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
Date:9/3/2007

Inclusion of Gerresheimer Stock in the SDAX as Per September 6, 2007

Outside the Normal Schedule Decision on Possible Inclusion in the MDAX to be Taken on 5 September

DÜSSELDORF, Germany, September 3 /PRNewswire/ -- Gerresheimer AG has been listed in the Prime Standard of the Frankfurter Stock exchange since June 11, 2007, following one of the largest IPOs of the year, with a total issue volume of more than 900 million euros. Gerresheimer stock will be included in the SDAX index of Deutsche Borse, Frankfurt am Main, on September 6, 2007 outside the normal schedule.

Possible inclusion of Gerresheimer stock in the MDAX index is independent of this decision. Changes in the composition of the selection indices are to be published by Deutsche Borse this coming Wednesday, 5 September.

Dr. Axel Herberg, CEO of Gerresheimer AG, in welcoming the decision, says: "We are pleased that our stock is to be included in the SDAX outside the normal schedule after only three months on the stock exchange and thereby becomes even more attractive."

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 37 production sites in Europe, North America and Asia and employs approximately 10,000 employees worldwide.

Contact

Burkhard Lingenberg

Director Corporate PR & Marketing

Telefon +49-211-6181-250

Telefax +49-211-6181-241

e-mail b.lingenberg@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. The Dangers Of Vitamin A To Pregnant Women To Be Included On Label
2. Hepatitis B Vaccine To Be Included In National Immunization Programme
3. ISRO To Expand Telemedicine Network, 4 Speciality Hospitals To Be Included
4. Meningitis Vaccine To Be Included In Childhood Immunization Programme
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. Eight More African Countries Included In US Malaria Program
7. Yoga, to Be Included in Schools as Part of the Curriculum
8. A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List
9. Gene linked to early puberty in girls
10. Cancer drugs in development nearly doubled since 1995
11. Nearly all asthma deaths preventable
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 1Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 2Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 3Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 4Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 5Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 6Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 7Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 8Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 9Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 10Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 11Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT 28R 29 Insert 6025 12Complete Horse Genome Sequence Revealed 60783 1Complete Horse Genome Sequence Revealed 60783 2Newly revised guidelines for managing thyroid cancer published in Thyroid journal 60779 1Newly revised guidelines for managing thyroid cancer published in Thyroid journal 60779 2